[{"Assets_0_Q2_USD":453957000.0,"CIK":"1628171","CommonStockSharesConverted_0_Q2_shares":59015868.0,"CommonStockSharesOutstanding_0_Q2_shares":59015868.0,"Country":"United States","EarningsPerShareBasic_1_Q2_USD":-0.46,"EarningsPerShareBasic_2_Q2_USD":-1.11,"Industry":"Specialty Chemicals","Market":"NASDAQ","Market Cap":"1775342076.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-48009000.0,"NetIncomeLossConverted_1_Q2_USD":-27215000.0,"NetIncomeLossConverted_2_Q2_USD":-46734000.0,"OfficialName":"Revolution Medicines Inc. Common Stock","RevenuesConverted_1_Q2_USD":10025000.0,"RevenuesConverted_2_Q2_USD":21571000.0,"SP500":"nan","Sector":"Consumer Durables","StockholdersEquity_0_Q2_USD":360498000.0,"Ticker":"RVMD","filed":"20200810","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2020.0","name":"REVOLUTION MEDICINES, INC.","period":"20200630","qtrs":"1","uom":"USD"}]